Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PolyAMiner-Bulk: A Machine Learning Based Bioinformatics Algorithm to Infer and Decode Alternative Polyadenylation Dynamics from bulk RNA-seq data. | bioRxiv | 2023 | 36747700 | PubTator, text mining | PubMed |
| Failed down-regulation of PI3K signaling makes autoreactive B cells receptive to bystander T cell help. | bioRxiv | 2023 | 36747655 | PubTator, text mining | PubMed |
| Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. | Biochem Pharmacol | 2023 | 36731803 | PubTator, text mining | PubMed |
| Deep learning predicts the impact of regulatory variants on cell-type-specific enhancers in the brain. | Bioinform Adv | 2023 | 36726730 | PubTator, text mining | PubMed |
| MicroRNAs in Macrophages: Regulators of Activation and Function. | J Immunol | 2023 | 36724439 | PubTator, text mining | PubMed |
| Conformational rearrangements in the second voltage sensor domain switch PIP2- and voltage-gating modes in two-pore channels. | Proc Natl Acad Sci U S A | 2023 | 36724253 | PubTator, text mining | PubMed |
| Structures of the Inhibitory Receptor Siglec-8 in Complex with a High-Affinity Sialoside Analogue and a Therapeutic Antibody. | JACS Au | 2023 | 36711084 | PubTator, text mining | PubMed |
| MiR-155 regulates M2 polarization of hepatitis B virus-infected tumour-associated macrophages which in turn regulates the malignant progression of hepatocellular carcinoma. | J Viral Hepat | 2023 | 36704832 | PubTator, text mining | PubMed |
| Expression of MicroRNA-155 in Patients with Non-Hodgkin Lymphoma, Coronavirus Disease 2019, or Both: A Cross-Sectional Study. | Iran J Med Sci | 2023 | 36688191 | PubTator, text mining | PubMed |
| Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases. | Life (Basel) | 2023 | 36676170 | PubTator, text mining | PubMed |
| CD96 as a Potential Immune Regulator in Cancers. | Int J Mol Sci | 2023 | 36674817 | PubTator, text mining | PubMed |
| SHIP1 Controls Internal Platelet Contraction and αIIbβ3 Integrin Dynamics in Early Platelet Activation. | Int J Mol Sci | 2023 | 36674478 | PubTator, text mining | PubMed |
| The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia. | Genes (Basel) | 2023 | 36672872 | PubTator, text mining | PubMed |
| The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 36672378 | PubTator, text mining | PubMed |
| The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy. | Haematologica | 2023 | 36655432 | PubTator, text mining | PubMed |
| Rejection markers in kidney transplantation: do new technologies help children? | Pediatr Nephrol | 2023 | 36648536 | PubTator, text mining | PubMed |
| CD19 Is Internalized Together with IgM in Proportion to B Cell Receptor Stimulation and Is Modulated by Phosphatidylinositol 3-Kinase in Bone Marrow Immature B Cells. | Immunohorizons | 2023 | 36637517 | PubTator, text mining | PubMed |
| Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno. | Lung Cancer (Auckl) | 2023 | 36636263 | PubTator, text mining | PubMed |
| Drug delivery targets and strategies to address mast cell diseases. | Expert Opin Drug Deliv | 2023 | 36629456 | PubTator, text mining | PubMed |
| Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor α Axis. | Gastroenterology | 2023 | 36623778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=20